ENVERIC BIOSCIENCES, INC. Stock Issued During Period, Value, Acquisitions
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, acquisitions for the quarter ending 2018-12-31 was $0.00.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, acquisitions for the quarter ending 2018-09-30 was $0.00.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, acquisitions for the quarter ending 2018-06-30 was $0.00.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, acquisitions for the quarter ending 2018-03-31 was $605.22K.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, acquisitions for fiscal 2020 was $1.90M.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, acquisitions for fiscal 2018 was $605.22K, a 83.98% decline from fiscal 2017.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, acquisitions for fiscal 2017 was $3.78M, a 44.94% increase from fiscal 2016.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, acquisitions for fiscal 2016 was $2.61M.
| Period end | Stock Issued During Period, Value, Acquisitions 3 month | Stock Issued During Period, Value, Acquisitions 12 month |
|---|---|---|
| 2020-12-31 | $1.90M 10-K · filed 2022-03-31 | |
| 2018-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-12 | $605.22K 10-K/A · filed 2020-08-12 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | |
| 2018-03-31 | $605.22K 10-Q · filed 2019-05-14 | |
| 2017-12-31 | $3.78M 10-K · filed 2019-03-26 | |
| 2016-12-31 | $2.61M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |